These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36118868)

  • 21. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma.
    Geng W; Lv Z; Fan J; Xu J; Mao K; Yin Z; Qing W; Jin Y
    Front Cell Dev Biol; 2021; 9():657667. PubMed ID: 33855028
    [No Abstract]   [Full Text] [Related]  

  • 23. Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.
    Liang Y; Ye F; Cheng Z; Ou Y; Zou L; Hu Y; Hu J; Jiang H
    Cancer Cell Int; 2021 Sep; 21(1):476. PubMed ID: 34496843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu S; Liu Z; Wu X; Luo H
    Front Oncol; 2022; 12():799475. PubMed ID: 35433487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of genomic instability-associated long non-coding RNA signature: A prognostic risk model of clear cell renal cell carcinoma.
    Jiang D; Wu T; Shi N; Shan Y; Wang J; Jiang H; Wu Y; Wang M; Li J; Liu H; Chen M
    Front Oncol; 2022; 12():1019011. PubMed ID: 36387102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of somatic mutator-derived and immune infiltrates related lncRNA signatures of genome instability reveals potential prognostic biomarkers involved in non-small cell lung cancer.
    Yang CZ; Yang T; Liu XT; He CF; Guo W; Liu S; Yao XH; Xiao X; Zeng WR; Lin LZ; Huang ZY
    Front Genet; 2022; 13():982030. PubMed ID: 36226174
    [No Abstract]   [Full Text] [Related]  

  • 27. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y; Li S; Wang X; Yi M; Wei H; Rong S; Zheng K; Zhang L
    Front Immunol; 2022; 13():929846. PubMed ID: 35990656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma.
    Yan Y; Ren L; Liu Y; Liu L
    Front Genet; 2021; 12():763281. PubMed ID: 35154241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
    Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
    Front Genet; 2021; 12():720013. PubMed ID: 34777461
    [No Abstract]   [Full Text] [Related]  

  • 30. Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma.
    Cao Y; Zhu H; Liu W; Wang L; Yin W; Tan J; Zhou Q; Xin Z; Huang H; Xie D; Zhao M; Jiang X; Peng J; Ren C
    Front Genet; 2021; 12():758596. PubMed ID: 35069679
    [No Abstract]   [Full Text] [Related]  

  • 31. A Genomic Instability-Related Long Noncoding RNA Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Lu J; Cao W; He Z; Wang H; Hao J; Xu J
    J Oncol; 2022; 2022():3090523. PubMed ID: 36072979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
    Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
    Jing L; Du Y; Fu D
    Front Genet; 2022; 13():979575. PubMed ID: 36105083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer.
    Chen H; Yu Y; Zhou L; Chen J; Li Z; Tan X
    Front Genet; 2023; 14():1049454. PubMed ID: 36713077
    [No Abstract]   [Full Text] [Related]  

  • 38. Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis.
    Wang X; Zhang H; Ye J; Gao M; Jiang Q; Zhao T; Wang S; Mao W; Wang K; Wang Q; Chen X; Hou X; Han D
    Front Genet; 2022; 13():850888. PubMed ID: 35571034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel 8-genome instability-associated lncRNAs signature predicting prognosis and drug sensitivity in gastric cancer.
    Yi C; Zhang X; Chen X; Huang B; Song J; Ma M; Yuan X; Zhang C
    Int J Immunopathol Pharmacol; 2022; 36():3946320221103195. PubMed ID: 35696730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.